Back to User profile » Dr Mitesh Borad
Papers published by Dr Mitesh Borad:
Key Considerations for Targeting KRAS in Pancreatic Cancer: Potential Impact on the Treatment Paradigm
Eslinger C, Sonbol MB, George B, Babiker H, Borad MJ, Bekaii-Saab TS
Drug Design, Development and Therapy 2026, 20:559325
Published Date: 27 March 2026
Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials
Imperial R, Mosalem O, Majeed U, Tran NH, Borad MJ, Babiker H
Clinical and Experimental Gastroenterology 2024, 17:121-134
Published Date: 18 April 2024
Clinical Utility of Ivosidenib in the Treatment of IDH1-Mutant Cholangiocarcinoma: Evidence To Date
Uson Junior PLS, Borad MJ
Cancer Management and Research 2023, 15:1025-1031
Published Date: 18 September 2023
Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma [Corrigendum]
Babiker HM, Riaz IR, Husnain M, Borad MJ
Oncolytic Virotherapy 2019, 8:1-2
Published Date: 4 January 2019
Oncolytic virotherapy in upper gastrointestinal tract cancers
Yokoda R, Nagalo BM, Arora M, Egan JB, Bogenberger JM, DeLeon TT, Zhou Y, Ahn DH, Borad MJ
Oncolytic Virotherapy 2018, 7:13-24
Published Date: 23 March 2018
Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
Yokoda R, Nagalo BM, Vernon B, Oklu R, Albadawi H, DeLeon TT, Zhou Y, Egan JB, Duda DG, Borad MJ
Oncolytic Virotherapy 2017, 6:39-49
Published Date: 8 November 2017
Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma
Babiker HM, Riaz IB, Husnain M, Borad MJ
Oncolytic Virotherapy 2017, 6:11-18
Published Date: 9 February 2017